Desipramine Treatment of Cocaine Dependence in Methadone-Maintained Patients
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
We performed a double-blind, placebo-controlled, randomized 12-week trial of desipramine hydrochloride treatment of cocaine dependence among methadone-maintained patients. Fifty-nine patients completed the 12-week medication trial (36 received desipramine and 23 received placebo), and 94% were recontacted 1, 3, and 6 months after treatment. There were significantly more dropouts in the desipramine than in the placebo group. Baseline to 12-week comparisons of Addiction Severity Index interview data indicated that both groups showed improvements. At 12 weeks, the desipramine group showed significantly better psychiatric status than the placebo group but did not differ from the placebo group on any of 21 other outcome measures, including cocaine use. During the 12-week medication phase and at the 1-month follow-up evaluation, urine toxicology screenings showed no significant difference between groups, but the placebo group had significantly less cocaine use at both the 3- and 6-month follow-up points. We conclude that desipramine has few benefits with regard to control of cocaine use in this population.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This includes two trials in primary cocaine use disorder (desipramine 200mg/d for 8 weeks (58) and up to 300mg/d for 12 weeks (59)) and a single report in methadone maintained participants with cocaine use disorder for desipramine (250-300mg/d for 12 weeks (60)) in improving psychiatric status.”
From Clinical management of psychostimulant withdrawal: review of the evidence (2023) · cites this paper as [60]
In the citing paper
“Three trials of desipramine report significant improvement along depressive symptoms over placebo for cocaine use disorder. This includes two trials in primary cocaine use disorder (desipramine 200mg/d for 8 weeks (58) and up to 300mg/d for 12 weeks (59)) and a single report in methadone maintained participants with cocaine use disorder for desipramine (250-300mg/d for 12 weeks (60)) in improving”
From Clinical management of psychostimulant withdrawal: review of the evidence (2023) · cites this paper as [60]
Citations
Cites
Applied Multiple Regression/Correlation Analysis for the Behavioral Sciences
Cohen, P., Cohen, P., West, S. G., & Aiken, L. S. (2014) · Psychology Press eBooks · doi:10.4324/9781410606266 · Cited by 20,737
Robins, L. N. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780290015001 · Cited by 5,219
McLELLAN, A. T., LUBORSKY, L., WOODY, G. E., & O??BRIEN, C. P. (1980) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198001000-00006 · Cited by 3,188
Tests for Linear Trends in Proportions and Frequencies
Armitage, P. (1955) · Biometrics · doi:10.2307/3001775 · Cited by 2,071
Desipramine Facilitation of Initial Cocaine Abstinence
Gawin, F. H. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810020019004 · Cited by 361
Cocaine Abuse Treatment: Open Pilot Trial With Desipramine and Lithium Carbonate
Gawin, F. H. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790200085011 · Cited by 289
A 2.5-Year Follow-up of Cocaine Use Among Treated Opioid Addicts: Have Our Treatments Helped?
Kosten, T. R. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800150101012 · Cited by 182
Protracted elimination of cocaine metabolites in long-term, high-dose cocaine abusers
Weiss, R. D., & Gawin, F. H. (1988) · The American Journal of Medicine · doi:10.1016/s0002-9343(88)80042-1 · Cited by 145
Cocaine Abuse among Opioid Addicts: Demographic and Diagnostic Factors in Treatment
Kosten, T. R., Gawin, F. H., Rounsaville, B. J., & Kleber, H. D. (1986) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952998609083739 · Cited by 131
Treatment of Depression in Chronic Cocaine and Phencyclidine Abuse With Desipramine
Giannini, A. J., Malone, D. A., Giannini, M. C., Price, W. A., & Loiselle, R. H. (1986) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1986.tb02936.x · Cited by 92
Cited by
Psychiatric and Substance Use Comorbidity Among Treatment-Seeking Opioid Abusers
Brooner, R. K. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830130077015 · Cited by 746
Carroll, K. M. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950120061010 · Cited by 409
Kreek, M. J., LaForge, K. S., & Butelman, E. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd897 · Cited by 374
Efficacy of antidepressants in substance use disorders with and without comorbid depression
Torrens, M., Fonseca, F., Mateu, G., & Farré, M. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.09.004 · Cited by 261
Monoamine transporters and psychostimulant addiction
Howell, L. L., & Kimmel, H. L. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.08.003 · Cited by 255
Metadata
- Authors
- Arndt, I. O.
- Affiliations
- Philadelphia VA Medical Center (US)
- Corresponding author
- Arndt, Isabelle O.
- Venue
- Archives of General Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 1992-11-01
- Volume
- 49
- Issue
- 11
- Pages
- 888
- ISSN
- 0003-990X (ISSN-L)
- OpenAlex
- W2128020995
- Cited by
- 139
- References
- 16
- Citations by year
- 2025: 2 · 2023: 2 · 2022: 2 · 2021: 3 · 2020: 2 · 2019: 2 · 2017: 2 · 2015: 3 · 2014: 2 · 2013: 1
- FWCI
- 7.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Archives of General Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (1r01da003997-01)
- National Institute on Drug Abuse (DA-05186, DA-03997)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- desipramine, cocaine dependence, methadone maintenance treatment, tricyclic antidepressants, cocaine use, relapse, Addiction Severity Index, mental health status, treatment discontinuation, addiction treatment
- MeSH terms
- Adult, Cocaine, Desipramine, Double-Blind Method, Drug Therapy, Combination, Follow-Up Studies, Humans, Male, Methadone, Middle Aged, Opioid-Related Disorders, Patient Dropouts, Placebos, Severity of Illness Index, Substance Abuse Detection, Comorbidity, Treatment Outcome, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Desipramine Treatment of Cocaine Dependence in Methadone-Maintained Patients. https://app.cochat.ai/papers/10.1001/archpsyc.1992.01820110052008
- The paper
- Arndt, I. O. (1992). Desipramine Treatment of Cocaine Dependence in Methadone-Maintained Patients. Archives of General Psychiatry. https://doi.org/10.1001/archpsyc.1992.01820110052008
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.